US Patent Issued to Ischemia Care on Aug. 25 for "Biomarkers for the diagnosis of atrial fibrillation cause of stroke" (Ohio Inventor)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,716,097, issued on Aug. 25, was assigned to Ischemia Care LLC (Oxford, Ohio).

"Biomarkers for the diagnosis of atrial fibrillation cause of stroke" was invented by Jeffrey Gerard June (Oxford, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides gene expression profiles useful for diagnosing atrial fibrillation in ischemic stroke and for distinguishing atrial fibrillation in ischemic stroke from arterial (large vessel) stroke or embolic stroke of undetermined source (ESUS). In another aspect, the present invention is the provision of an improved method for prognosis of an outcome or assessing the risk of a patient having suffered ...